Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) shares are trading higher by 5.4% to $32.68, gaining after initially falling, after the company priced an underwritten registered offering of about 15.79 million shares of its common stock at $28.50 per share, expecting to close around
Equity and crypto trading company Robinhood Markets Inc (NASDAQ: HOOD) reported fourth-quarter financial results after the market close Wednesday. Here are the key highlights.